Data from Thomas Jefferson University Provide New Insights into Prostate Cancer (The NOGO receptor NgR2, a novel aVb3 integrin effector, induces neuroendocrine differentiation in prostate cancer)

Press/Media

PeriodNov 29 2022

Media coverage

1

Media coverage

  • TitleData from Thomas Jefferson University Provide New Insights into Prostate Cancer (The NOGO receptor NgR2, a novel aVb3 integrin effector, induces neuroendocrine differentiation in prostate cancer)
    Media name/outletCancer Daily
    Country/TerritoryUnited States
    Date11/29/22
    PersonsPeter A. McCue
View all 1
View less

Related content